Combinatorial pharmacogenetics-guided treatment did not demonstrate improved outcomes compared to treatment-as-usual in adolescents with depression, and future research should examine specific ...
SALT LAKE CITY, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, announced today the peer-reviewed journal Psychiatry Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results